与癌症和抗癌疗法相关的血栓形成的潜在机制
Despoina Pantazi1, Dimitrios Alivertis2, Alexandros D Tselepis3
1Laboratory of Biochemistry, Department of Chemistry/Atherothrombosis Research Centre, University of Ioannina, 451 10, Ioannina, Epirus, Greece. dpantazi@uoi.gr.
Current treatment options in oncology
|June 11, 2024
概括
与癌症相关的血栓形成 (CAT) 是主要的死亡原因,抗癌药物如氨酸激酶抑制剂 (TKIs) 增加了静脉和动脉事件的风险. 了解CAT机制和优化抗凝策略对于患者的治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌症相关血栓形成 (CAT) 是癌症患者死亡的主要原因.
- 抗癌疗法,特别是氨酸激酶抑制剂 (TKIs),增加了血栓事件的风险.
- 静脉血栓栓塞 (VTE) 和动脉血栓塞 (ATE) 事件都是CAT的重大并发症.
研究的目的:
- 提供对CAT背后的病态机制的最新审查.
- 检查抗癌药物的影响,特别是TKI,对血栓形成的发展.
- 讨论当前和潜在的抗凝策略来管理CAT.
主要方法:
- 文献综述和对CAT现有研究的综合.
- 对癌症中前列血栓机制的分析.
- 评估针对性治疗在CAT中的作用.
主要成果:
- 癌症诱导高凝血状态,促进凝血激活和细胞相互作用.
- 技术知识与其他向治疗可以加剧VTE和ATE的风险.
- 精确的CAT病理机制是复杂的,并没有完全阐明.
结论:
- 有效管理CAT需要全面了解其多因素性质.
- 抗凝血策略必须平衡血栓形成的预防与出血风险,考虑FXIa抑制剂,DOAC和LMWH等药物.
- 进一步的研究对于开发用于减少CAT的新和更安全的策略至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
675
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
675
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Disorders of Hemostasis
837
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
837
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


